Type 1 Interferon as an Antiinflammatory Agent: Inhibition of Lipopolysaccharide-Induced Interleukin-lβ and Induction of Interleukin-1 Receptor Antagonist (Q71939001)

From Wikidata

Jump to navigation Jump to search

scientific article published on 01 April 1995

Language	Label	Description	Also known as
English	Type 1 Interferon as an Antiinflammatory Agent: Inhibition of Lipopolysaccharide-Induced Interleukin-lβ and Induction of Interleukin-1 Receptor Antagonist	scientific article published on 01 April 1995

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7627806%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

Type 1 interferon as an antiinflammatory agent: inhibition of lipopolysaccharide-induced interleukin-1 beta and induction of interleukin-1 receptor antagonist (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7627806%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

Type 1 Interferon as an Antiinflammatory Agent: Inhibition of Lipopolysaccharide-Induced Interleukin-lβ and Induction of Interleukin-1 Receptor Antagonist (English)

1 reference

10.1089/JIR.1995.15.317

https://api.crossref.org/works/10.1089/JIR.1995.15.317

19 June 2024

lipopolysaccharide

1 reference

based on heuristic

inferred from title

author name string

Y. Huang

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7627806

19 June 2024

L. M. Blatt

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7627806

19 June 2024

M. W. Taylor

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7627806

19 June 2024

language of work or name

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=7627806

19 June 2024

publication date

1 April 1995

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7627806%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

full work available at URL

http://www.liebertpub.com/doi/pdf/10.1089/jir.1995.15.317

1 reference

10.1089/JIR.1995.15.317

https://api.crossref.org/works/10.1089/JIR.1995.15.317

19 June 2024

Journal of Interferon and Cytokine Research

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7627806%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

15

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7627806%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7627806%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

317-321

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7627806%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

Treatment of chronic hepatitis C with recombinant interferon alfa. A multicenter randomized, controlled trial

1

1 reference

10.1089/JIR.1995.15.317

https://api.crossref.org/works/10.1089/JIR.1995.15.317

19 June 2024

Recombinant interferon alfa therapy for chronic hepatitis C. A randomized, double-blind, placebo-controlled trial

2

1 reference

10.1089/JIR.1995.15.317

https://api.crossref.org/works/10.1089/JIR.1995.15.317

19 June 2024

Randomized, controlled trial of recombinant human alpha-interferon in patients with chronic hepatitis B

3

1 reference

10.1089/JIR.1995.15.317

https://api.crossref.org/works/10.1089/JIR.1995.15.317

19 June 2024

A comparison of interferon-Con1 with natural recombinant interferons-alpha: antiviral, antiproliferative, and natural killer-inducing activities

4

1 reference

10.1089/JIR.1995.15.317

https://api.crossref.org/works/10.1089/JIR.1995.15.317

19 June 2024

Direct stimulation of cytokines (IL-1 beta, TNF-alpha, IL-6, IL-2, IFN-gamma and GM-CSF) in whole blood. I. Comparison with isolated PBMC stimulation

5

1 reference

10.1089/JIR.1995.15.317

https://api.crossref.org/works/10.1089/JIR.1995.15.317

19 June 2024

Influence of collection and separation of blood samples on plasma IL-1, IL-6 and TNF-alpha concentrations

7

1 reference

10.1089/JIR.1995.15.317

https://api.crossref.org/works/10.1089/JIR.1995.15.317

19 June 2024

Interleukin (IL) 4 differentially regulates monocyte IL-1 family gene expression and synthesis in vitro and in vivo

8

1 reference

10.1089/JIR.1995.15.317

https://api.crossref.org/works/10.1089/JIR.1995.15.317

19 June 2024

Biological properties of recombinant human monocyte-derived interleukin 1 receptor antagonist

11

1 reference

10.1089/JIR.1995.15.317

https://api.crossref.org/works/10.1089/JIR.1995.15.317

19 June 2024

Purification, cloning, expression and biological characterization of an interleukin-1 receptor antagonist protein

13

1 reference

10.1089/JIR.1995.15.317

https://api.crossref.org/works/10.1089/JIR.1995.15.317

19 June 2024

Induction of the interleukin 1 receptor antagonist protein by transforming growth factor-β

16

1 reference

10.1089/JIR.1995.15.317

https://api.crossref.org/works/10.1089/JIR.1995.15.317

19 June 2024

The synthesis of IL-1 receptor antagonist (IL-1ra) by synovial fibroblasts is markedly increased by the cytokines TNF-alpha and IL-1

18

1 reference

10.1089/JIR.1995.15.317

https://api.crossref.org/works/10.1089/JIR.1995.15.317

19 June 2024

Prostaglandin E2 and collagenase production by fibroblasts and synovial cells is regulated by urine-derived human interleukin 1 and inhibitor(s)

19

1 reference

10.1089/JIR.1995.15.317

https://api.crossref.org/works/10.1089/JIR.1995.15.317

19 June 2024

Identifiers

10.1089/JIR.1995.15.317

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7627806%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7627806%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q71939001&oldid=2183979760"